When AI Finds the Signal, Medicine Still Has to Finish the Job
The next serious test for healthcare AI is not whether it can notice something humans might miss. It is whether the health system can turn that notice into completed care.
The Four-Day Difference: What England’s AI Lung-Cancer Rollout Says About Healthcare Delivery
England’s national AI chest X-ray rollout is a useful test of healthcare AI’s real promise: not just detecting a signal, but moving patients faster from scan to diagnosis, follow-up, and…
The OPTIMA Verdict: Two-Thirds of High-Risk Breast Cancer Patients Can Safely Skip Chemotherapy
A landmark phase 3 trial of 4,429 patients showed the Prosigna 50-gene genomic test can safely spare two-thirds of clinically high-risk breast cancer patients from chemotherapy, with equivalent five-year survival…
How to Shop for an MRI Without Getting Lost in the Price Maze
A practical guide to getting the right MRI at the right place without being blindsided by CPT codes, facility fees, radiologist bills, network rules, cash prices, and deductible math.
The $2,500 MRI Question: Why Healthcare Prices Still Hide in Plain Sight
Why the same MRI can be a medical miracle, a billing maze, and a test case for whether healthcare price transparency can actually help patients before they book care.
ASCO 2026’s Most Consequential Lung Cancer Result: Ivonescimab Cuts Death Risk by 34% in Squamous NSCLC
At ASCO 2026’s plenary session, ivonescimab, a first-in-class bispecific antibody targeting PD-1 and VEGF, cut the risk of death by 34% in advanced squamous NSCLC, becoming the first drug to…
The Pathologist’s New Microscope: How Foundation Models Like Virchow 2, CHIEF, and Prov-GigaPath Are Quietly Transforming Cancer Diagnosis in 2026
A new class of AI foundation models trained on millions of whole slide images is reshaping how cancer is diagnosed. Inside Virchow 2, Prov-GigaPath, CHIEF, and the FDA clearance of…
The Lp(a) Reckoning: Why the 2026 ACC/AHA Guidelines Just Rewrote the Rules of Heart Disease Prevention
For the first time in U.S. medical history, every adult is being told to measure a single genetic blood marker that explains a hidden quarter of heart attack risk. Inside…
AI in Medicine | Diagnostics & Early Detection | Healthcare | Healthcare AI Governance | Healthcare PE & Venture
AI Case Finding: The Healthcare Delivery Use Case That Finds Patients Medicine Keeps Missing
AI case finding may be one of the most important healthcare delivery use cases of 2026: finding patients who already qualify for proven care but remain invisible to the system.
Every Baby a Genome: How Newborn Sequencing Is Reinventing Precision Medicine
GUARDIAN, BEACONS, BabySeq2, BeginNGS, and the NHS Generation Study are running in parallel in 2026. Inside the 12-fold detection signal from Columbia, the $14.4 million NIH multi-state pilot, and what…
